Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP New designation follows the U.S. Food and Drug ...

Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia (AML). AB8939 had already obtained orphan drug designation from the ...

An EU committee is recommending that tranilast, the active ingredient in a pulmonary fibrosis drug candidate, be awarded ...

2 The European Medicines Agency (EMA) received 2,302 such applications between the introduction of the regulation in 2000 and September 2015, of which its Committee for Orphan Medicinal Products ...

The French pharma said it will file the drug, based on the active ingredient odevixibat, under a new trade name as a treatment for ALGS, after the Committee for Orphan Medicinal Products (COMP ...

that it has received notification from the European Medicines Agency's ("EMA") Committee for Orphan Medicinal Products ("COMP") of its positive opinion regarding Orphan Drug Designation ("ODD") in ...

AB Science SA (Euronext - FR0010557264 - AB) announces today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the ...

AB Science SA (Euronext - FR0010557264 - AB) announces today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the ...

Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia (AML). AB8939 had already obtained orphan drug designation from the US ...